nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—Toremifene—breast cancer	0.238	0.614	CrCtD
Diphenhydramine—Tamoxifen—breast cancer	0.149	0.386	CrCtD
Diphenhydramine—PTGS1—breast cancer	0.0684	0.595	CbGaD
Diphenhydramine—CYP2D6—breast cancer	0.0466	0.405	CbGaD
Diphenhydramine—Bifonazole—Letrozole—breast cancer	0.0415	0.156	CrCrCtD
Diphenhydramine—Bedaquiline—Toremifene—breast cancer	0.022	0.0825	CrCrCtD
Diphenhydramine—Clomifene—Toremifene—breast cancer	0.02	0.0751	CrCrCtD
Diphenhydramine—CYP2B6—Thiotepa—breast cancer	0.0156	0.108	CbGbCtD
Diphenhydramine—Bedaquiline—Tamoxifen—breast cancer	0.0138	0.0518	CrCrCtD
Diphenhydramine—Clomifene—Tamoxifen—breast cancer	0.0126	0.0471	CrCrCtD
Diphenhydramine—CYP1A2—Anastrozole—breast cancer	0.0121	0.0837	CbGbCtD
Diphenhydramine—CYP1A2—Toremifene—breast cancer	0.011	0.0765	CbGbCtD
Diphenhydramine—Naftifine—Toremifene—breast cancer	0.011	0.0413	CrCrCtD
Diphenhydramine—CYP2C9—Anastrozole—breast cancer	0.0109	0.0754	CbGbCtD
Diphenhydramine—Cloperastine—Raloxifene—breast cancer	0.0105	0.0393	CrCrCtD
Diphenhydramine—CYP2B6—Raloxifene—breast cancer	0.0104	0.0721	CbGbCtD
Diphenhydramine—Tamoxifen—Toremifene—breast cancer	0.00913	0.0342	CrCrCtD
Diphenhydramine—SLC22A2—Vinblastine—breast cancer	0.00903	0.0627	CbGbCtD
Diphenhydramine—CYP2C19—Lapatinib—breast cancer	0.00872	0.0605	CbGbCtD
Diphenhydramine—Toremifene—Tamoxifen—breast cancer	0.00835	0.0313	CrCrCtD
Diphenhydramine—CYP2C9—Idarubicin—breast cancer	0.00823	0.0571	CbGbCtD
Diphenhydramine—Doxylamine—Toremifene—breast cancer	0.00764	0.0286	CrCrCtD
Diphenhydramine—CYP2D6—Idarubicin—breast cancer	0.00753	0.0522	CbGbCtD
Diphenhydramine—Phenoxybenzamine—Toremifene—breast cancer	0.00725	0.0272	CrCrCtD
Diphenhydramine—Dextropropoxyphene—Toremifene—breast cancer	0.00725	0.0272	CrCrCtD
Diphenhydramine—Naftifine—Tamoxifen—breast cancer	0.00691	0.0259	CrCrCtD
Diphenhydramine—CYP2B6—Tamoxifen—breast cancer	0.00687	0.0477	CbGbCtD
Diphenhydramine—Bromodiphenhydramine—Toremifene—breast cancer	0.00646	0.0242	CrCrCtD
Diphenhydramine—Methadyl Acetate—Tamoxifen—breast cancer	0.00555	0.0208	CrCrCtD
Diphenhydramine—Levomethadyl Acetate—Tamoxifen—breast cancer	0.00555	0.0208	CrCrCtD
Diphenhydramine—CYP2B6—Irinotecan—breast cancer	0.00528	0.0366	CbGbCtD
Diphenhydramine—Clofedanol—Toremifene—breast cancer	0.00524	0.0197	CrCrCtD
Diphenhydramine—Cyclobenzaprine—Tamoxifen—breast cancer	0.00522	0.0196	CrCrCtD
Diphenhydramine—Benzphetamine—Toremifene—breast cancer	0.00508	0.019	CrCrCtD
Diphenhydramine—Orphenadrine—Toremifene—breast cancer	0.00508	0.019	CrCrCtD
Diphenhydramine—Doxylamine—Tamoxifen—breast cancer	0.0048	0.018	CrCrCtD
Diphenhydramine—Benzyl Benzoate—Toremifene—breast cancer	0.0047	0.0176	CrCrCtD
Diphenhydramine—Phenoxybenzamine—Tamoxifen—breast cancer	0.00456	0.0171	CrCrCtD
Diphenhydramine—Dextropropoxyphene—Tamoxifen—breast cancer	0.00456	0.0171	CrCrCtD
Diphenhydramine—CYP2C9—Capecitabine—breast cancer	0.00451	0.0313	CbGbCtD
Diphenhydramine—CYP2C19—Tamoxifen—breast cancer	0.00437	0.0303	CbGbCtD
Diphenhydramine—Tripelennamine—Tamoxifen—breast cancer	0.00434	0.0163	CrCrCtD
Diphenhydramine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.00406	0.0152	CrCrCtD
Diphenhydramine—Dimetacrine—Tamoxifen—breast cancer	0.00406	0.0152	CrCrCtD
Diphenhydramine—CYP1A2—Tamoxifen—breast cancer	0.00403	0.0279	CbGbCtD
Diphenhydramine—Methadone—Tamoxifen—breast cancer	0.00381	0.0143	CrCrCtD
Diphenhydramine—CYP2D6—Vinorelbine—breast cancer	0.00368	0.0255	CbGbCtD
Diphenhydramine—CYP2C9—Tamoxifen—breast cancer	0.00363	0.0252	CbGbCtD
Diphenhydramine—CYP2D6—Tamoxifen—breast cancer	0.00332	0.023	CbGbCtD
Diphenhydramine—Clofedanol—Tamoxifen—breast cancer	0.00329	0.0124	CrCrCtD
Diphenhydramine—Orphenadrine—Tamoxifen—breast cancer	0.00319	0.012	CrCrCtD
Diphenhydramine—Benzphetamine—Tamoxifen—breast cancer	0.00319	0.012	CrCrCtD
Diphenhydramine—Promazine—Tamoxifen—breast cancer	0.00304	0.0114	CrCrCtD
Diphenhydramine—CYP1A2—Fluorouracil—breast cancer	0.00297	0.0206	CbGbCtD
Diphenhydramine—Benzyl Benzoate—Tamoxifen—breast cancer	0.00295	0.0111	CrCrCtD
Diphenhydramine—CYP2B6—Doxorubicin—breast cancer	0.00288	0.02	CbGbCtD
Diphenhydramine—CYP2C9—Paclitaxel—breast cancer	0.00282	0.0196	CbGbCtD
Diphenhydramine—CYP2C9—Fluorouracil—breast cancer	0.00267	0.0186	CbGbCtD
Diphenhydramine—CYP2D6—Vinblastine—breast cancer	0.00227	0.0157	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—breast cancer	0.00139	0.00966	CbGbCtD
Diphenhydramine—SLC22A5—mammary gland—breast cancer	0.000132	0.0481	CbGeAlD
Diphenhydramine—CYP2C18—endocrine gland—breast cancer	0.000121	0.0439	CbGeAlD
Diphenhydramine—Tamoxifen—ESRRA—breast cancer	0.00012	0.0643	CrCbGaD
Diphenhydramine—CYP2C9—mammary gland—breast cancer	0.000114	0.0413	CbGeAlD
Diphenhydramine—SLC22A5—nipple—breast cancer	0.000109	0.0397	CbGeAlD
Diphenhydramine—CYP1A2—nipple—breast cancer	9.89e-05	0.036	CbGeAlD
Diphenhydramine—Dimetacrine—ACHE—breast cancer	9.68e-05	0.0517	CrCbGaD
Diphenhydramine—HRH1—nipple—breast cancer	9.26e-05	0.0337	CbGeAlD
Diphenhydramine—Tamoxifen—SULT1A1—breast cancer	9.12e-05	0.0487	CrCbGaD
Diphenhydramine—PTGS1—nipple—breast cancer	8.57e-05	0.0312	CbGeAlD
Diphenhydramine—SLC22A1—adipose tissue—breast cancer	8.55e-05	0.0311	CbGeAlD
Diphenhydramine—Bifonazole—CYP17A1—breast cancer	7.59e-05	0.0406	CrCbGaD
Diphenhydramine—SLC22A5—skin of body—breast cancer	6.99e-05	0.0255	CbGeAlD
Diphenhydramine—CHRM2—endocrine gland—breast cancer	6.77e-05	0.0246	CbGeAlD
Diphenhydramine—SLC22A1—endocrine gland—breast cancer	6.65e-05	0.0242	CbGeAlD
Diphenhydramine—SLC22A5—endometrium—breast cancer	6.59e-05	0.024	CbGeAlD
Diphenhydramine—HRH1—epithelium—breast cancer	6.24e-05	0.0227	CbGeAlD
Diphenhydramine—CYP2B6—skin of body—breast cancer	6.07e-05	0.0221	CbGeAlD
Diphenhydramine—SLC22A5—pituitary gland—breast cancer	5.97e-05	0.0217	CbGeAlD
Diphenhydramine—SLC22A5—adipose tissue—breast cancer	5.94e-05	0.0216	CbGeAlD
Diphenhydramine—PTGS1—epithelium—breast cancer	5.77e-05	0.021	CbGeAlD
Diphenhydramine—HRH1—endometrium—breast cancer	5.59e-05	0.0204	CbGeAlD
Diphenhydramine—Cyclopentolate—BCHE—breast cancer	5.57e-05	0.0298	CrCbGaD
Diphenhydramine—PTGS1—skin of body—breast cancer	5.49e-05	0.02	CbGeAlD
Diphenhydramine—SLC22A5—female reproductive system—breast cancer	5.46e-05	0.0199	CbGeAlD
Diphenhydramine—SLC22A5—adrenal gland—breast cancer	5.33e-05	0.0194	CbGeAlD
Diphenhydramine—PTGS1—endometrium—breast cancer	5.18e-05	0.0188	CbGeAlD
Diphenhydramine—CYP2C19—endocrine gland—breast cancer	5.13e-05	0.0187	CbGeAlD
Diphenhydramine—HRH1—adipose tissue—breast cancer	5.04e-05	0.0183	CbGeAlD
Diphenhydramine—SLC22A5—female gonad—breast cancer	4.97e-05	0.0181	CbGeAlD
Diphenhydramine—Bedaquiline—CYP3A4—breast cancer	4.94e-05	0.0264	CrCbGaD
Diphenhydramine—Vomiting—Goserelin—breast cancer	4.78e-05	0.00103	CcSEcCtD
Diphenhydramine—Paraesthesia—Fluorouracil—breast cancer	4.78e-05	0.00103	CcSEcCtD
Diphenhydramine—PTGS1—uterus—breast cancer	4.77e-05	0.0174	CbGeAlD
Diphenhydramine—Constipation—Mitoxantrone—breast cancer	4.75e-05	0.00102	CcSEcCtD
Diphenhydramine—Constipation—Irinotecan—breast cancer	4.75e-05	0.00102	CcSEcCtD
Diphenhydramine—CYP2B6—female reproductive system—breast cancer	4.74e-05	0.0173	CbGeAlD
Diphenhydramine—Rash—Goserelin—breast cancer	4.74e-05	0.00102	CcSEcCtD
Diphenhydramine—Dermatitis—Goserelin—breast cancer	4.74e-05	0.00102	CcSEcCtD
Diphenhydramine—Somnolence—Fluorouracil—breast cancer	4.73e-05	0.00102	CcSEcCtD
Diphenhydramine—Headache—Goserelin—breast cancer	4.71e-05	0.00101	CcSEcCtD
Diphenhydramine—Decreased appetite—Gemcitabine—breast cancer	4.7e-05	0.00101	CcSEcCtD
Diphenhydramine—CYP2C9—female reproductive system—breast cancer	4.7e-05	0.0171	CbGeAlD
Diphenhydramine—Chills—Capecitabine—breast cancer	4.69e-05	0.00101	CcSEcCtD
Diphenhydramine—PTGS1—pituitary gland—breast cancer	4.68e-05	0.017	CbGeAlD
Diphenhydramine—Dyspepsia—Fluorouracil—breast cancer	4.68e-05	0.00101	CcSEcCtD
Diphenhydramine—Nausea—Tamoxifen—breast cancer	4.68e-05	0.00101	CcSEcCtD
Diphenhydramine—PTGS1—adipose tissue—breast cancer	4.67e-05	0.017	CbGeAlD
Diphenhydramine—Fatigue—Gemcitabine—breast cancer	4.66e-05	0.001	CcSEcCtD
Diphenhydramine—HRH1—female reproductive system—breast cancer	4.63e-05	0.0169	CbGeAlD
Diphenhydramine—CYP2B6—adrenal gland—breast cancer	4.63e-05	0.0168	CbGeAlD
Diphenhydramine—Constipation—Gemcitabine—breast cancer	4.63e-05	0.000997	CcSEcCtD
Diphenhydramine—Decreased appetite—Fluorouracil—breast cancer	4.62e-05	0.000996	CcSEcCtD
Diphenhydramine—Dry mouth—Paclitaxel—breast cancer	4.62e-05	0.000995	CcSEcCtD
Diphenhydramine—Asthenia—Thiotepa—breast cancer	4.61e-05	0.000994	CcSEcCtD
Diphenhydramine—Diarrhoea—Vinorelbine—breast cancer	4.61e-05	0.000992	CcSEcCtD
Diphenhydramine—Nausea—Melphalan—breast cancer	4.58e-05	0.000986	CcSEcCtD
Diphenhydramine—Feeling abnormal—Irinotecan—breast cancer	4.58e-05	0.000986	CcSEcCtD
Diphenhydramine—Feeling abnormal—Mitoxantrone—breast cancer	4.58e-05	0.000986	CcSEcCtD
Diphenhydramine—Confusional state—Paclitaxel—breast cancer	4.57e-05	0.000984	CcSEcCtD
Diphenhydramine—Dysuria—Methotrexate—breast cancer	4.55e-05	0.00098	CcSEcCtD
Diphenhydramine—HRH1—adrenal gland—breast cancer	4.52e-05	0.0165	CbGeAlD
Diphenhydramine—Nausea—Goserelin—breast cancer	4.47e-05	0.000962	CcSEcCtD
Diphenhydramine—Feeling abnormal—Gemcitabine—breast cancer	4.46e-05	0.00096	CcSEcCtD
Diphenhydramine—Dizziness—Vinorelbine—breast cancer	4.45e-05	0.000959	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Methotrexate—breast cancer	4.44e-05	0.000957	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Paclitaxel—breast cancer	4.43e-05	0.000955	CcSEcCtD
Diphenhydramine—Tachycardia—Paclitaxel—breast cancer	4.42e-05	0.000952	CcSEcCtD
Diphenhydramine—Urticaria—Mitoxantrone—breast cancer	4.41e-05	0.00095	CcSEcCtD
Diphenhydramine—Diarrhoea—Thiotepa—breast cancer	4.4e-05	0.000948	CcSEcCtD
Diphenhydramine—Feeling abnormal—Fluorouracil—breast cancer	4.38e-05	0.000944	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Paclitaxel—breast cancer	4.38e-05	0.000943	CcSEcCtD
Diphenhydramine—Drowsiness—Methotrexate—breast cancer	4.34e-05	0.000935	CcSEcCtD
Diphenhydramine—Anorexia—Paclitaxel—breast cancer	4.32e-05	0.00093	CcSEcCtD
Diphenhydramine—Vision blurred—Capecitabine—breast cancer	4.29e-05	0.000925	CcSEcCtD
Diphenhydramine—PTGS1—female reproductive system—breast cancer	4.29e-05	0.0156	CbGeAlD
Diphenhydramine—Vomiting—Vinorelbine—breast cancer	4.28e-05	0.000922	CcSEcCtD
Diphenhydramine—Tremor—Capecitabine—breast cancer	4.27e-05	0.000919	CcSEcCtD
Diphenhydramine—Dysuria—Epirubicin—breast cancer	4.26e-05	0.000917	CcSEcCtD
Diphenhydramine—Dizziness—Thiotepa—breast cancer	4.25e-05	0.000916	CcSEcCtD
Diphenhydramine—Rash—Vinorelbine—breast cancer	4.25e-05	0.000915	CcSEcCtD
Diphenhydramine—Dermatitis—Vinorelbine—breast cancer	4.24e-05	0.000914	CcSEcCtD
Diphenhydramine—Hypotension—Paclitaxel—breast cancer	4.23e-05	0.000912	CcSEcCtD
Diphenhydramine—Urticaria—Fluorouracil—breast cancer	4.23e-05	0.00091	CcSEcCtD
Diphenhydramine—Headache—Vinorelbine—breast cancer	4.22e-05	0.000909	CcSEcCtD
Diphenhydramine—HRH1—female gonad—breast cancer	4.22e-05	0.0153	CbGeAlD
Diphenhydramine—Pollakiuria—Epirubicin—breast cancer	4.21e-05	0.000906	CcSEcCtD
Diphenhydramine—CYP1A2—endocrine gland—breast cancer	4.19e-05	0.0152	CbGeAlD
Diphenhydramine—PTGS1—adrenal gland—breast cancer	4.18e-05	0.0152	CbGeAlD
Diphenhydramine—Palpitations—Docetaxel—breast cancer	4.16e-05	0.000895	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Epirubicin—breast cancer	4.16e-05	0.000895	CcSEcCtD
Diphenhydramine—Insomnia—Paclitaxel—breast cancer	4.1e-05	0.000882	CcSEcCtD
Diphenhydramine—Vertigo—Capecitabine—breast cancer	4.09e-05	0.000881	CcSEcCtD
Diphenhydramine—Vomiting—Thiotepa—breast cancer	4.09e-05	0.000881	CcSEcCtD
Diphenhydramine—Convulsion—Docetaxel—breast cancer	4.08e-05	0.000878	CcSEcCtD
Diphenhydramine—Paraesthesia—Paclitaxel—breast cancer	4.07e-05	0.000876	CcSEcCtD
Diphenhydramine—Drowsiness—Epirubicin—breast cancer	4.06e-05	0.000875	CcSEcCtD
Diphenhydramine—Rash—Thiotepa—breast cancer	4.05e-05	0.000873	CcSEcCtD
Diphenhydramine—Dermatitis—Thiotepa—breast cancer	4.05e-05	0.000873	CcSEcCtD
Diphenhydramine—Agranulocytosis—Methotrexate—breast cancer	4.05e-05	0.000872	CcSEcCtD
Diphenhydramine—Headache—Thiotepa—breast cancer	4.03e-05	0.000868	CcSEcCtD
Diphenhydramine—Somnolence—Paclitaxel—breast cancer	4.03e-05	0.000867	CcSEcCtD
Diphenhydramine—Palpitations—Capecitabine—breast cancer	4.02e-05	0.000867	CcSEcCtD
Diphenhydramine—CYP2B6—endocrine gland—breast cancer	4.01e-05	0.0146	CbGeAlD
Diphenhydramine—Nausea—Vinorelbine—breast cancer	4e-05	0.000862	CcSEcCtD
Diphenhydramine—Dyspepsia—Paclitaxel—breast cancer	3.99e-05	0.000859	CcSEcCtD
Diphenhydramine—Asthenia—Mitoxantrone—breast cancer	3.98e-05	0.000858	CcSEcCtD
Diphenhydramine—Asthenia—Irinotecan—breast cancer	3.98e-05	0.000858	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Epirubicin—breast cancer	3.98e-05	0.000857	CcSEcCtD
Diphenhydramine—CYP2C9—endocrine gland—breast cancer	3.98e-05	0.0145	CbGeAlD
Diphenhydramine—Toremifene—ESR1—breast cancer	3.96e-05	0.0211	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS1—breast cancer	3.94e-05	0.0211	CrCbGaD
Diphenhydramine—Dysuria—Doxorubicin—breast cancer	3.94e-05	0.000849	CcSEcCtD
Diphenhydramine—Decreased appetite—Paclitaxel—breast cancer	3.94e-05	0.000848	CcSEcCtD
Diphenhydramine—HRH1—endocrine gland—breast cancer	3.92e-05	0.0143	CbGeAlD
Diphenhydramine—Dry mouth—Docetaxel—breast cancer	3.92e-05	0.000844	CcSEcCtD
Diphenhydramine—Fatigue—Paclitaxel—breast cancer	3.9e-05	0.000841	CcSEcCtD
Diphenhydramine—PTGS1—female gonad—breast cancer	3.9e-05	0.0142	CbGeAlD
Diphenhydramine—Pollakiuria—Doxorubicin—breast cancer	3.89e-05	0.000838	CcSEcCtD
Diphenhydramine—Asthenia—Gemcitabine—breast cancer	3.88e-05	0.000836	CcSEcCtD
Diphenhydramine—Constipation—Paclitaxel—breast cancer	3.87e-05	0.000834	CcSEcCtD
Diphenhydramine—Confusional state—Docetaxel—breast cancer	3.87e-05	0.000834	CcSEcCtD
Diphenhydramine—Bifonazole—CYP19A1—breast cancer	3.86e-05	0.0206	CrCbGaD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—breast cancer	3.85e-05	0.000828	CcSEcCtD
Diphenhydramine—Nausea—Thiotepa—breast cancer	3.82e-05	0.000823	CcSEcCtD
Diphenhydramine—Diarrhoea—Mitoxantrone—breast cancer	3.8e-05	0.000819	CcSEcCtD
Diphenhydramine—Diarrhoea—Irinotecan—breast cancer	3.8e-05	0.000819	CcSEcCtD
Diphenhydramine—Dry mouth—Capecitabine—breast cancer	3.79e-05	0.000817	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—breast cancer	3.79e-05	0.000816	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Docetaxel—breast cancer	3.76e-05	0.00081	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—breast cancer	3.76e-05	0.000809	CcSEcCtD
Diphenhydramine—Confusional state—Capecitabine—breast cancer	3.75e-05	0.000807	CcSEcCtD
Diphenhydramine—Tachycardia—Docetaxel—breast cancer	3.75e-05	0.000807	CcSEcCtD
Diphenhydramine—Feeling abnormal—Paclitaxel—breast cancer	3.73e-05	0.000804	CcSEcCtD
Diphenhydramine—Clomifene—CYP19A1—breast cancer	3.72e-05	0.0199	CrCbGaD
Diphenhydramine—Diarrhoea—Gemcitabine—breast cancer	3.7e-05	0.000797	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—breast cancer	3.68e-05	0.000793	CcSEcCtD
Diphenhydramine—Dizziness—Irinotecan—breast cancer	3.67e-05	0.000791	CcSEcCtD
Diphenhydramine—Anorexia—Docetaxel—breast cancer	3.66e-05	0.000788	CcSEcCtD
Diphenhydramine—Diarrhoea—Fluorouracil—breast cancer	3.64e-05	0.000784	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Capecitabine—breast cancer	3.64e-05	0.000784	CcSEcCtD
Diphenhydramine—Tinnitus—Methotrexate—breast cancer	3.63e-05	0.000782	CcSEcCtD
Diphenhydramine—PTGS1—endocrine gland—breast cancer	3.63e-05	0.0132	CbGeAlD
Diphenhydramine—Tachycardia—Capecitabine—breast cancer	3.63e-05	0.000781	CcSEcCtD
Diphenhydramine—Urticaria—Paclitaxel—breast cancer	3.6e-05	0.000775	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Capecitabine—breast cancer	3.59e-05	0.000774	CcSEcCtD
Diphenhydramine—Hypotension—Docetaxel—breast cancer	3.59e-05	0.000773	CcSEcCtD
Diphenhydramine—Anorexia—Capecitabine—breast cancer	3.54e-05	0.000763	CcSEcCtD
Diphenhydramine—Vomiting—Irinotecan—breast cancer	3.53e-05	0.000761	CcSEcCtD
Diphenhydramine—Vomiting—Mitoxantrone—breast cancer	3.53e-05	0.000761	CcSEcCtD
Diphenhydramine—CYP2D6—female reproductive system—breast cancer	3.52e-05	0.0128	CbGeAlD
Diphenhydramine—Dizziness—Fluorouracil—breast cancer	3.52e-05	0.000758	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—breast cancer	3.51e-05	0.000755	CcSEcCtD
Diphenhydramine—Rash—Mitoxantrone—breast cancer	3.5e-05	0.000754	CcSEcCtD
Diphenhydramine—Rash—Irinotecan—breast cancer	3.5e-05	0.000754	CcSEcCtD
Diphenhydramine—Dermatitis—Mitoxantrone—breast cancer	3.5e-05	0.000754	CcSEcCtD
Diphenhydramine—Dermatitis—Irinotecan—breast cancer	3.5e-05	0.000754	CcSEcCtD
Diphenhydramine—Chills—Methotrexate—breast cancer	3.49e-05	0.000753	CcSEcCtD
Diphenhydramine—Headache—Irinotecan—breast cancer	3.48e-05	0.000749	CcSEcCtD
Diphenhydramine—Headache—Mitoxantrone—breast cancer	3.48e-05	0.000749	CcSEcCtD
Diphenhydramine—Hypotension—Capecitabine—breast cancer	3.47e-05	0.000748	CcSEcCtD
Diphenhydramine—Insomnia—Docetaxel—breast cancer	3.47e-05	0.000748	CcSEcCtD
Diphenhydramine—Paraesthesia—Docetaxel—breast cancer	3.45e-05	0.000743	CcSEcCtD
Diphenhydramine—Vomiting—Gemcitabine—breast cancer	3.44e-05	0.000741	CcSEcCtD
Diphenhydramine—Clomifene—ESR1—breast cancer	3.42e-05	0.0183	CrCbGaD
Diphenhydramine—Somnolence—Docetaxel—breast cancer	3.41e-05	0.000735	CcSEcCtD
Diphenhydramine—Rash—Gemcitabine—breast cancer	3.41e-05	0.000735	CcSEcCtD
Diphenhydramine—Dermatitis—Gemcitabine—breast cancer	3.41e-05	0.000734	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—breast cancer	3.4e-05	0.000732	CcSEcCtD
Diphenhydramine—Headache—Gemcitabine—breast cancer	3.39e-05	0.00073	CcSEcCtD
Diphenhydramine—Vomiting—Fluorouracil—breast cancer	3.38e-05	0.000729	CcSEcCtD
Diphenhydramine—Dyspepsia—Docetaxel—breast cancer	3.38e-05	0.000728	CcSEcCtD
Diphenhydramine—Insomnia—Capecitabine—breast cancer	3.36e-05	0.000724	CcSEcCtD
Diphenhydramine—Rash—Fluorouracil—breast cancer	3.35e-05	0.000722	CcSEcCtD
Diphenhydramine—Dermatitis—Fluorouracil—breast cancer	3.35e-05	0.000722	CcSEcCtD
Diphenhydramine—Paraesthesia—Capecitabine—breast cancer	3.34e-05	0.000719	CcSEcCtD
Diphenhydramine—Decreased appetite—Docetaxel—breast cancer	3.34e-05	0.000719	CcSEcCtD
Diphenhydramine—Headache—Fluorouracil—breast cancer	3.33e-05	0.000718	CcSEcCtD
Diphenhydramine—Fatigue—Docetaxel—breast cancer	3.31e-05	0.000713	CcSEcCtD
Diphenhydramine—Nausea—Mitoxantrone—breast cancer	3.3e-05	0.000711	CcSEcCtD
Diphenhydramine—Nausea—Irinotecan—breast cancer	3.3e-05	0.000711	CcSEcCtD
Diphenhydramine—Constipation—Docetaxel—breast cancer	3.28e-05	0.000707	CcSEcCtD
Diphenhydramine—Dyspepsia—Capecitabine—breast cancer	3.27e-05	0.000705	CcSEcCtD
Diphenhydramine—Chills—Epirubicin—breast cancer	3.27e-05	0.000704	CcSEcCtD
Diphenhydramine—Fenoprofen—PTGS1—breast cancer	3.26e-05	0.0174	CrCbGaD
Diphenhydramine—Asthenia—Paclitaxel—breast cancer	3.25e-05	0.0007	CcSEcCtD
Diphenhydramine—Decreased appetite—Capecitabine—breast cancer	3.23e-05	0.000696	CcSEcCtD
Diphenhydramine—Nausea—Gemcitabine—breast cancer	3.21e-05	0.000692	CcSEcCtD
Diphenhydramine—CYP2D6—female gonad—breast cancer	3.21e-05	0.0117	CbGeAlD
Diphenhydramine—Fatigue—Capecitabine—breast cancer	3.2e-05	0.00069	CcSEcCtD
Diphenhydramine—SLC22A5—lymph node—breast cancer	3.2e-05	0.0116	CbGeAlD
Diphenhydramine—Vision blurred—Methotrexate—breast cancer	3.2e-05	0.000688	CcSEcCtD
Diphenhydramine—Constipation—Capecitabine—breast cancer	3.18e-05	0.000685	CcSEcCtD
Diphenhydramine—Feeling abnormal—Docetaxel—breast cancer	3.16e-05	0.000681	CcSEcCtD
Diphenhydramine—Toremifene—CYP1A1—breast cancer	3.16e-05	0.0169	CrCbGaD
Diphenhydramine—Nausea—Fluorouracil—breast cancer	3.16e-05	0.000681	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—breast cancer	3.14e-05	0.000677	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—breast cancer	3.11e-05	0.000671	CcSEcCtD
Diphenhydramine—Diarrhoea—Paclitaxel—breast cancer	3.1e-05	0.000668	CcSEcCtD
Diphenhydramine—Nervousness—Epirubicin—breast cancer	3.08e-05	0.000664	CcSEcCtD
Diphenhydramine—Feeling abnormal—Capecitabine—breast cancer	3.06e-05	0.00066	CcSEcCtD
Diphenhydramine—Vertigo—Methotrexate—breast cancer	3.05e-05	0.000656	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—breast cancer	3.03e-05	0.000652	CcSEcCtD
Diphenhydramine—Dizziness—Paclitaxel—breast cancer	2.99e-05	0.000645	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—breast cancer	2.99e-05	0.000644	CcSEcCtD
Diphenhydramine—CYP2D6—endocrine gland—breast cancer	2.98e-05	0.0109	CbGeAlD
Diphenhydramine—Orphenadrine—SCN10A—breast cancer	2.97e-05	0.0159	CrCbGaD
Diphenhydramine—Reboxetine—CYP2D6—breast cancer	2.97e-05	0.0159	CrCbGaD
Diphenhydramine—Urticaria—Capecitabine—breast cancer	2.95e-05	0.000636	CcSEcCtD
Diphenhydramine—Convulsion—Methotrexate—breast cancer	2.94e-05	0.000633	CcSEcCtD
Diphenhydramine—Agitation—Epirubicin—breast cancer	2.92e-05	0.000628	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CYP19A1—breast cancer	2.9e-05	0.0155	CrCbGaD
Diphenhydramine—Tension—Doxorubicin—breast cancer	2.88e-05	0.000621	CcSEcCtD
Diphenhydramine—Vomiting—Paclitaxel—breast cancer	2.88e-05	0.00062	CcSEcCtD
Diphenhydramine—Rash—Paclitaxel—breast cancer	2.86e-05	0.000615	CcSEcCtD
Diphenhydramine—Dermatitis—Paclitaxel—breast cancer	2.85e-05	0.000615	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—breast cancer	2.85e-05	0.000614	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—breast cancer	2.85e-05	0.000614	CcSEcCtD
Diphenhydramine—Headache—Paclitaxel—breast cancer	2.84e-05	0.000611	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—breast cancer	2.8e-05	0.000604	CcSEcCtD
Diphenhydramine—Confusional state—Methotrexate—breast cancer	2.79e-05	0.000601	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—breast cancer	2.77e-05	0.000596	CcSEcCtD
Diphenhydramine—Asthenia—Docetaxel—breast cancer	2.75e-05	0.000593	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—breast cancer	2.75e-05	0.000592	CcSEcCtD
Diphenhydramine—Clomifene—CYP1A1—breast cancer	2.73e-05	0.0146	CrCbGaD
Diphenhydramine—HRH1—lymph node—breast cancer	2.71e-05	0.00986	CbGeAlD
Diphenhydramine—Thrombocytopenia—Methotrexate—breast cancer	2.71e-05	0.000584	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—breast cancer	2.7e-05	0.000581	CcSEcCtD
Diphenhydramine—Nausea—Paclitaxel—breast cancer	2.69e-05	0.00058	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methotrexate—breast cancer	2.67e-05	0.000576	CcSEcCtD
Diphenhydramine—Asthenia—Capecitabine—breast cancer	2.67e-05	0.000574	CcSEcCtD
Diphenhydramine—Dry mouth—Epirubicin—breast cancer	2.64e-05	0.000569	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—breast cancer	2.64e-05	0.000568	CcSEcCtD
Diphenhydramine—Anorexia—Methotrexate—breast cancer	2.64e-05	0.000568	CcSEcCtD
Diphenhydramine—Diarrhoea—Docetaxel—breast cancer	2.63e-05	0.000566	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—breast cancer	2.61e-05	0.000562	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS1—breast cancer	2.61e-05	0.0139	CrCbGaD
Diphenhydramine—Palpitations—Doxorubicin—breast cancer	2.59e-05	0.000559	CcSEcCtD
Diphenhydramine—Hypotension—Methotrexate—breast cancer	2.59e-05	0.000557	CcSEcCtD
Diphenhydramine—Tamoxifen—ESR2—breast cancer	2.56e-05	0.0137	CrCbGaD
Diphenhydramine—Reboxetine—CYP3A4—breast cancer	2.55e-05	0.0136	CrCbGaD
Diphenhydramine—Convulsion—Doxorubicin—breast cancer	2.54e-05	0.000548	CcSEcCtD
Diphenhydramine—Diarrhoea—Capecitabine—breast cancer	2.54e-05	0.000548	CcSEcCtD
Diphenhydramine—Dizziness—Docetaxel—breast cancer	2.54e-05	0.000547	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—breast cancer	2.54e-05	0.000546	CcSEcCtD
Diphenhydramine—Tachycardia—Epirubicin—breast cancer	2.53e-05	0.000544	CcSEcCtD
Diphenhydramine—PTGS1—lymph node—breast cancer	2.51e-05	0.00913	CbGeAlD
Diphenhydramine—Hyperhidrosis—Epirubicin—breast cancer	2.5e-05	0.000539	CcSEcCtD
Diphenhydramine—Insomnia—Methotrexate—breast cancer	2.5e-05	0.000539	CcSEcCtD
Diphenhydramine—Paraesthesia—Methotrexate—breast cancer	2.48e-05	0.000535	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—breast cancer	2.47e-05	0.000532	CcSEcCtD
Diphenhydramine—Somnolence—Methotrexate—breast cancer	2.46e-05	0.00053	CcSEcCtD
Diphenhydramine—Dizziness—Capecitabine—breast cancer	2.46e-05	0.000529	CcSEcCtD
Diphenhydramine—Tripelennamine—CYP2D6—breast cancer	2.45e-05	0.0131	CrCbGaD
Diphenhydramine—Dry mouth—Doxorubicin—breast cancer	2.44e-05	0.000527	CcSEcCtD
Diphenhydramine—Vomiting—Docetaxel—breast cancer	2.44e-05	0.000526	CcSEcCtD
Diphenhydramine—Dyspepsia—Methotrexate—breast cancer	2.44e-05	0.000525	CcSEcCtD
Diphenhydramine—Rash—Docetaxel—breast cancer	2.42e-05	0.000521	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—breast cancer	2.42e-05	0.000521	CcSEcCtD
Diphenhydramine—Dermatitis—Docetaxel—breast cancer	2.42e-05	0.000521	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—breast cancer	2.42e-05	0.00052	CcSEcCtD
Diphenhydramine—Decreased appetite—Methotrexate—breast cancer	2.41e-05	0.000518	CcSEcCtD
Diphenhydramine—Headache—Docetaxel—breast cancer	2.4e-05	0.000518	CcSEcCtD
Diphenhydramine—Fatigue—Methotrexate—breast cancer	2.39e-05	0.000514	CcSEcCtD
Diphenhydramine—Vomiting—Capecitabine—breast cancer	2.36e-05	0.000509	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—breast cancer	2.35e-05	0.000505	CcSEcCtD
Diphenhydramine—Rash—Capecitabine—breast cancer	2.34e-05	0.000505	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—breast cancer	2.34e-05	0.000505	CcSEcCtD
Diphenhydramine—Dermatitis—Capecitabine—breast cancer	2.34e-05	0.000504	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP1B1—breast cancer	2.34e-05	0.0125	CrCbGaD
Diphenhydramine—Tachycardia—Doxorubicin—breast cancer	2.34e-05	0.000504	CcSEcCtD
Diphenhydramine—Headache—Capecitabine—breast cancer	2.33e-05	0.000502	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—breast cancer	2.33e-05	0.000501	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—breast cancer	2.32e-05	0.000499	CcSEcCtD
Diphenhydramine—Somnolence—Epirubicin—breast cancer	2.3e-05	0.000496	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—breast cancer	2.28e-05	0.000492	CcSEcCtD
Diphenhydramine—Nausea—Docetaxel—breast cancer	2.28e-05	0.000491	CcSEcCtD
Diphenhydramine—Feeling abnormal—Methotrexate—breast cancer	2.28e-05	0.000491	CcSEcCtD
Diphenhydramine—Warfarin—CYP1A1—breast cancer	2.28e-05	0.0122	CrCbGaD
Diphenhydramine—Dyspepsia—Epirubicin—breast cancer	2.28e-05	0.000491	CcSEcCtD
Diphenhydramine—Oxaprozin—PTGS2—breast cancer	2.25e-05	0.0121	CrCbGaD
Diphenhydramine—Decreased appetite—Epirubicin—breast cancer	2.25e-05	0.000485	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—breast cancer	2.24e-05	0.000482	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—breast cancer	2.23e-05	0.000481	CcSEcCtD
Diphenhydramine—Constipation—Epirubicin—breast cancer	2.21e-05	0.000477	CcSEcCtD
Diphenhydramine—Nausea—Capecitabine—breast cancer	2.21e-05	0.000476	CcSEcCtD
Diphenhydramine—Urticaria—Methotrexate—breast cancer	2.2e-05	0.000474	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—breast cancer	2.17e-05	0.000467	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—breast cancer	2.15e-05	0.000463	CcSEcCtD
Diphenhydramine—Feeling abnormal—Epirubicin—breast cancer	2.13e-05	0.00046	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—breast cancer	2.13e-05	0.000459	CcSEcCtD
Diphenhydramine—Reboxetine—ABCB1—breast cancer	2.12e-05	0.0113	CrCbGaD
Diphenhydramine—Dyspepsia—Doxorubicin—breast cancer	2.11e-05	0.000454	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—breast cancer	2.08e-05	0.000449	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—breast cancer	2.07e-05	0.000445	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—breast cancer	2.06e-05	0.000443	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—breast cancer	2.05e-05	0.000441	CcSEcCtD
Diphenhydramine—Cyclobenzaprine—CYP2D6—breast cancer	2.03e-05	0.0109	CrCbGaD
Diphenhydramine—Toremifene—CYP3A4—breast cancer	2.02e-05	0.0108	CrCbGaD
Diphenhydramine—Asthenia—Methotrexate—breast cancer	1.99e-05	0.000428	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—breast cancer	1.97e-05	0.000425	CcSEcCtD
Diphenhydramine—Urticaria—Doxorubicin—breast cancer	1.9e-05	0.00041	CcSEcCtD
Diphenhydramine—Alimemazine—CYP3A4—breast cancer	1.89e-05	0.0101	CrCbGaD
Diphenhydramine—Diarrhoea—Methotrexate—breast cancer	1.89e-05	0.000408	CcSEcCtD
Diphenhydramine—Benzatropine—CYP2D6—breast cancer	1.88e-05	0.01	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—breast cancer	1.86e-05	0.00996	CrCbGaD
Diphenhydramine—Asthenia—Epirubicin—breast cancer	1.86e-05	0.0004	CcSEcCtD
Diphenhydramine—Dizziness—Methotrexate—breast cancer	1.83e-05	0.000394	CcSEcCtD
Diphenhydramine—Bifonazole—CYP3A4—breast cancer	1.81e-05	0.0097	CrCbGaD
Diphenhydramine—Cinnarizine—CYP1A1—breast cancer	1.81e-05	0.00966	CrCbGaD
Diphenhydramine—Diarrhoea—Epirubicin—breast cancer	1.77e-05	0.000382	CcSEcCtD
Diphenhydramine—Vomiting—Methotrexate—breast cancer	1.76e-05	0.000379	CcSEcCtD
Diphenhydramine—Cyclobenzaprine—CYP3A4—breast cancer	1.74e-05	0.00933	CrCbGaD
Diphenhydramine—Clomifene—CYP3A4—breast cancer	1.74e-05	0.00933	CrCbGaD
Diphenhydramine—Rash—Methotrexate—breast cancer	1.74e-05	0.000376	CcSEcCtD
Diphenhydramine—Dermatitis—Methotrexate—breast cancer	1.74e-05	0.000375	CcSEcCtD
Diphenhydramine—Headache—Methotrexate—breast cancer	1.73e-05	0.000373	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—breast cancer	1.72e-05	0.00037	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP19A1—breast cancer	1.72e-05	0.00918	CrCbGaD
Diphenhydramine—Dizziness—Epirubicin—breast cancer	1.71e-05	0.000369	CcSEcCtD
Diphenhydramine—Methadone—CYP19A1—breast cancer	1.7e-05	0.0091	CrCbGaD
Diphenhydramine—Toremifene—ABCB1—breast cancer	1.68e-05	0.00899	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP2D6—breast cancer	1.67e-05	0.00895	CrCbGaD
Diphenhydramine—Fenoprofen—ALB—breast cancer	1.66e-05	0.00887	CrCbGaD
Diphenhydramine—Vomiting—Epirubicin—breast cancer	1.65e-05	0.000355	CcSEcCtD
Diphenhydramine—Nausea—Methotrexate—breast cancer	1.64e-05	0.000354	CcSEcCtD
Diphenhydramine—Phenprocoumon—CYP3A4—breast cancer	1.64e-05	0.00877	CrCbGaD
Diphenhydramine—Diarrhoea—Doxorubicin—breast cancer	1.64e-05	0.000353	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—breast cancer	1.63e-05	0.000352	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—breast cancer	1.63e-05	0.000351	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—breast cancer	1.62e-05	0.000349	CcSEcCtD
Diphenhydramine—Tamoxifen—ABCG2—breast cancer	1.61e-05	0.00862	CrCbGaD
Diphenhydramine—Dizziness—Doxorubicin—breast cancer	1.58e-05	0.000341	CcSEcCtD
Diphenhydramine—Tamoxifen—ESR1—breast cancer	1.58e-05	0.00845	CrCbGaD
Diphenhydramine—Nausea—Epirubicin—breast cancer	1.54e-05	0.000331	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—breast cancer	1.52e-05	0.000328	CcSEcCtD
Diphenhydramine—Phenylbutazone—CYP3A4—breast cancer	1.52e-05	0.00814	CrCbGaD
Diphenhydramine—Rash—Doxorubicin—breast cancer	1.51e-05	0.000325	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—breast cancer	1.51e-05	0.000325	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—breast cancer	1.5e-05	0.000323	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS2—breast cancer	1.49e-05	0.00797	CrCbGaD
Diphenhydramine—Bepridil—CYP2D6—breast cancer	1.48e-05	0.0079	CrCbGaD
Diphenhydramine—Warfarin—CYP3A4—breast cancer	1.46e-05	0.00778	CrCbGaD
Diphenhydramine—Clomifene—ABCB1—breast cancer	1.45e-05	0.00777	CrCbGaD
Diphenhydramine—Brompheniramine—CYP2D6—breast cancer	1.45e-05	0.00775	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP3A4—breast cancer	1.44e-05	0.00767	CrCbGaD
Diphenhydramine—Phenprocoumon—ALB—breast cancer	1.43e-05	0.00765	CrCbGaD
Diphenhydramine—Nausea—Doxorubicin—breast cancer	1.42e-05	0.000307	CcSEcCtD
Diphenhydramine—Chlorphenamine—CYP2D6—breast cancer	1.42e-05	0.00761	CrCbGaD
Diphenhydramine—Dextropropoxyphene—CYP2D6—breast cancer	1.37e-05	0.00735	CrCbGaD
Diphenhydramine—Levomethadyl Acetate—CYP3A4—breast cancer	1.36e-05	0.00729	CrCbGaD
Diphenhydramine—Cinnarizine—CYP2D6—breast cancer	1.34e-05	0.00719	CrCbGaD
Diphenhydramine—Warfarin—ALB—breast cancer	1.27e-05	0.00679	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A1—breast cancer	1.26e-05	0.00675	CrCbGaD
Diphenhydramine—Brompheniramine—CYP3A4—breast cancer	1.24e-05	0.00665	CrCbGaD
Diphenhydramine—Chlorphenamine—CYP3A4—breast cancer	1.22e-05	0.00652	CrCbGaD
Diphenhydramine—Atomoxetine—CYP2D6—breast cancer	1.2e-05	0.00639	CrCbGaD
Diphenhydramine—Modafinil—CYP3A4—breast cancer	1.19e-05	0.00637	CrCbGaD
Diphenhydramine—Dextropropoxyphene—CYP3A4—breast cancer	1.18e-05	0.0063	CrCbGaD
Diphenhydramine—Fentanyl—CYP3A4—breast cancer	1.17e-05	0.00623	CrCbGaD
Diphenhydramine—Phenytoin—CYP3A4—breast cancer	1.06e-05	0.00565	CrCbGaD
Diphenhydramine—Bepridil—ABCB1—breast cancer	1.06e-05	0.00564	CrCbGaD
Diphenhydramine—Benzphetamine—CYP3A4—breast cancer	1.03e-05	0.00553	CrCbGaD
Diphenhydramine—Atomoxetine—CYP3A4—breast cancer	1.03e-05	0.00548	CrCbGaD
Diphenhydramine—Phenoxybenzamine—CYP3A4—breast cancer	9.88e-06	0.00528	CrCbGaD
Diphenhydramine—Trimipramine—CYP2D6—breast cancer	9.83e-06	0.00526	CrCbGaD
Diphenhydramine—Fentanyl—ABCB1—breast cancer	9.71e-06	0.00519	CrCbGaD
Diphenhydramine—Promethazine—CYP2D6—breast cancer	9.47e-06	0.00506	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2D6—breast cancer	9.4e-06	0.00503	CrCbGaD
Diphenhydramine—Doxepin—CYP2D6—breast cancer	9.37e-06	0.00501	CrCbGaD
Diphenhydramine—Methadone—CYP2D6—breast cancer	9.32e-06	0.00498	CrCbGaD
Diphenhydramine—Phenytoin—ALB—breast cancer	9.22e-06	0.00493	CrCbGaD
Diphenhydramine—Phenytoin—ABCB1—breast cancer	8.8e-06	0.00471	CrCbGaD
Diphenhydramine—Trimipramine—CYP3A4—breast cancer	8.43e-06	0.00451	CrCbGaD
Diphenhydramine—Tamoxifen—CYP3A4—breast cancer	8.06e-06	0.00431	CrCbGaD
Diphenhydramine—Doxepin—CYP3A4—breast cancer	8.04e-06	0.0043	CrCbGaD
Diphenhydramine—Methadone—CYP3A4—breast cancer	7.99e-06	0.00427	CrCbGaD
Diphenhydramine—Orphenadrine—CYP3A4—breast cancer	7.83e-06	0.00419	CrCbGaD
Diphenhydramine—Imipramine—CYP2D6—breast cancer	7.29e-06	0.0039	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2D6—breast cancer	7.25e-06	0.00387	CrCbGaD
Diphenhydramine—Promazine—CYP3A4—breast cancer	7.14e-06	0.00382	CrCbGaD
Diphenhydramine—Trimipramine—ABCB1—breast cancer	7.02e-06	0.00375	CrCbGaD
Diphenhydramine—Promethazine—ABCB1—breast cancer	6.76e-06	0.00361	CrCbGaD
Diphenhydramine—Tamoxifen—ABCB1—breast cancer	6.71e-06	0.00359	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—breast cancer	6.69e-06	0.00358	CrCbGaD
Diphenhydramine—Methadone—ABCB1—breast cancer	6.66e-06	0.00356	CrCbGaD
Diphenhydramine—Imipramine—CYP3A4—breast cancer	6.25e-06	0.00334	CrCbGaD
Diphenhydramine—Amitriptyline—CYP3A4—breast cancer	6.22e-06	0.00332	CrCbGaD
Diphenhydramine—Amitriptyline—ALB—breast cancer	5.42e-06	0.0029	CrCbGaD
Diphenhydramine—Imipramine—ABCB1—breast cancer	5.21e-06	0.00278	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—breast cancer	5.17e-06	0.00277	CrCbGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—breast cancer	1.26e-06	3.45e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—STK11—breast cancer	1.26e-06	3.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP19A1—breast cancer	1.26e-06	3.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ITPR1—breast cancer	1.25e-06	3.44e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—FASN—breast cancer	1.25e-06	3.44e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NOS3—breast cancer	1.25e-06	3.43e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—BCHE—breast cancer	1.25e-06	3.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LEP—breast cancer	1.25e-06	3.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CAV1—breast cancer	1.24e-06	3.39e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC5A5—breast cancer	1.23e-06	3.38e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LEP—breast cancer	1.23e-06	3.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—breast cancer	1.22e-06	3.35e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CAV1—breast cancer	1.22e-06	3.33e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCB1—breast cancer	1.21e-06	3.31e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—breast cancer	1.2e-06	3.3e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NOS3—breast cancer	1.2e-06	3.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ESR1—breast cancer	1.19e-06	3.27e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NQO1—breast cancer	1.19e-06	3.26e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC2A1—breast cancer	1.19e-06	3.26e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—breast cancer	1.19e-06	3.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TYMS—breast cancer	1.19e-06	3.25e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—breast cancer	1.18e-06	3.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.18e-06	3.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—COMT—breast cancer	1.18e-06	3.23e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FN1—breast cancer	1.18e-06	3.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—breast cancer	1.17e-06	3.21e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ESR1—breast cancer	1.17e-06	3.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NCOR1—breast cancer	1.17e-06	3.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.17e-06	3.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—breast cancer	1.17e-06	3.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—COMT—breast cancer	1.17e-06	3.2e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.17e-06	3.2e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NFKBIA—breast cancer	1.16e-06	3.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—breast cancer	1.16e-06	3.19e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP3A4—breast cancer	1.16e-06	3.18e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FN1—breast cancer	1.16e-06	3.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMOX1—breast cancer	1.16e-06	3.17e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—breast cancer	1.16e-06	3.17e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.16e-06	3.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ITPR1—breast cancer	1.15e-06	3.16e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOTCH1—breast cancer	1.15e-06	3.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—breast cancer	1.15e-06	3.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMOX1—breast cancer	1.15e-06	3.14e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—breast cancer	1.15e-06	3.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	1.14e-06	3.14e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ITPR1—breast cancer	1.14e-06	3.14e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1B1—breast cancer	1.14e-06	3.13e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	1.13e-06	3.11e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—breast cancer	1.13e-06	3.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—breast cancer	1.13e-06	3.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KIT—breast cancer	1.13e-06	3.09e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPX1—breast cancer	1.12e-06	3.08e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.12e-06	3.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGF—breast cancer	1.11e-06	3.05e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A1—breast cancer	1.11e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—breast cancer	1.11e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCB1—breast cancer	1.11e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	1.11e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KIT—breast cancer	1.11e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—breast cancer	1.11e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ERCC2—breast cancer	1.1e-06	3.02e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCB1—breast cancer	1.1e-06	3.02e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—breast cancer	1.1e-06	3.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGF—breast cancer	1.1e-06	3e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—breast cancer	1.09e-06	3e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TYMS—breast cancer	1.09e-06	2.99e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NCOA1—breast cancer	1.09e-06	2.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TYMS—breast cancer	1.08e-06	2.96e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK3—breast cancer	1.08e-06	2.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NCOR1—breast cancer	1.08e-06	2.95e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—breast cancer	1.08e-06	2.95e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.08e-06	2.95e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—STK11—breast cancer	1.07e-06	2.94e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP19A1—breast cancer	1.07e-06	2.94e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NCOR1—breast cancer	1.07e-06	2.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.07e-06	2.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—breast cancer	1.07e-06	2.93e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	1.06e-06	2.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—breast cancer	1.06e-06	2.9e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—breast cancer	1.04e-06	2.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—breast cancer	1.04e-06	2.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPX1—breast cancer	1.03e-06	2.83e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—breast cancer	1.03e-06	2.83e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT2—breast cancer	1.03e-06	2.82e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—breast cancer	1.03e-06	2.82e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—breast cancer	1.03e-06	2.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPX1—breast cancer	1.02e-06	2.8e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.02e-06	2.8e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—breast cancer	1.01e-06	2.78e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT2—breast cancer	1.01e-06	2.78e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ERCC2—breast cancer	1.01e-06	2.78e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A1—breast cancer	1.01e-06	2.78e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—breast cancer	1.01e-06	2.77e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—breast cancer	1.01e-06	2.77e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.01e-06	2.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ERCC2—breast cancer	1e-06	2.75e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—breast cancer	9.99e-07	2.74e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—breast cancer	9.99e-07	2.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—COMT—breast cancer	9.98e-07	2.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—breast cancer	9.94e-07	2.72e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—breast cancer	9.9e-07	2.71e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	9.81e-07	2.69e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMOX1—breast cancer	9.8e-07	2.69e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—breast cancer	9.8e-07	2.68e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ITPR1—breast cancer	9.78e-07	2.68e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	9.74e-07	2.67e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—breast cancer	9.7e-07	2.66e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	9.65e-07	2.64e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	9.64e-07	2.64e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—breast cancer	9.6e-07	2.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NOS3—breast cancer	9.56e-07	2.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAV1—breast cancer	9.55e-07	2.62e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—breast cancer	9.54e-07	2.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—breast cancer	9.53e-07	2.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—breast cancer	9.44e-07	2.59e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCB1—breast cancer	9.41e-07	2.58e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOS3—breast cancer	9.35e-07	2.56e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TYMS—breast cancer	9.24e-07	2.53e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOS3—breast cancer	9.2e-07	2.52e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PLA2G4A—breast cancer	9.13e-07	2.5e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—breast cancer	9.13e-07	2.5e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NCOR1—breast cancer	9.13e-07	2.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.13e-07	2.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—breast cancer	8.94e-07	2.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	8.91e-07	2.44e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MDM2—breast cancer	8.87e-07	2.43e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAF1—breast cancer	8.84e-07	2.42e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—breast cancer	8.82e-07	2.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RELA—breast cancer	8.8e-07	2.41e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAV1—breast cancer	8.79e-07	2.41e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	8.77e-07	2.4e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—breast cancer	8.75e-07	2.4e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPX1—breast cancer	8.75e-07	2.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—breast cancer	8.74e-07	2.4e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MDM2—breast cancer	8.73e-07	2.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAV1—breast cancer	8.71e-07	2.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—breast cancer	8.7e-07	2.38e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAF1—breast cancer	8.7e-07	2.38e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RELA—breast cancer	8.66e-07	2.37e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1A1—breast cancer	8.66e-07	2.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MTOR—breast cancer	8.63e-07	2.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—breast cancer	8.63e-07	2.37e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—breast cancer	8.61e-07	2.36e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ERCC2—breast cancer	8.59e-07	2.35e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	8.49e-07	2.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MTOR—breast cancer	8.49e-07	2.33e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.32e-07	2.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—breast cancer	8.3e-07	2.27e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—breast cancer	8.24e-07	2.26e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—breast cancer	8.16e-07	2.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—breast cancer	8.11e-07	2.22e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—breast cancer	8.1e-07	2.22e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—breast cancer	8.07e-07	2.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—breast cancer	8.01e-07	2.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—breast cancer	8e-07	2.19e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	7.97e-07	2.18e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—breast cancer	7.94e-07	2.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—breast cancer	7.94e-07	2.17e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—breast cancer	7.93e-07	2.17e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—breast cancer	7.89e-07	2.16e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	7.88e-07	2.16e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—breast cancer	7.81e-07	2.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—breast cancer	7.8e-07	2.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—breast cancer	7.76e-07	2.13e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—breast cancer	7.73e-07	2.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JUN—breast cancer	7.71e-07	2.11e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—breast cancer	7.65e-07	2.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—breast cancer	7.65e-07	2.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—breast cancer	7.63e-07	2.09e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—breast cancer	7.6e-07	2.08e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JUN—breast cancer	7.59e-07	2.08e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—breast cancer	7.55e-07	2.07e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	7.53e-07	2.06e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—breast cancer	7.5e-07	2.06e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	7.48e-07	2.05e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—breast cancer	7.46e-07	2.04e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAV1—breast cancer	7.44e-07	2.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—breast cancer	7.38e-07	2.02e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	7.36e-07	2.02e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—breast cancer	7.34e-07	2.01e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK8—breast cancer	7.3e-07	2e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—breast cancer	7.28e-07	1.99e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—breast cancer	7.26e-07	1.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NOS3—breast cancer	7.22e-07	1.98e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK8—breast cancer	7.18e-07	1.97e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—breast cancer	7.16e-07	1.96e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.11e-07	1.95e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—breast cancer	7.05e-07	1.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—breast cancer	7.04e-07	1.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—breast cancer	6.98e-07	1.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—breast cancer	6.95e-07	1.9e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SRC—breast cancer	6.92e-07	1.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—breast cancer	6.89e-07	1.89e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SRC—breast cancer	6.81e-07	1.86e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—breast cancer	6.78e-07	1.86e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—breast cancer	6.77e-07	1.85e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—breast cancer	6.74e-07	1.85e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—breast cancer	6.67e-07	1.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—breast cancer	6.67e-07	1.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NOS3—breast cancer	6.64e-07	1.82e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—breast cancer	6.63e-07	1.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—breast cancer	6.61e-07	1.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NOS3—breast cancer	6.59e-07	1.8e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—breast cancer	6.56e-07	1.8e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK3—breast cancer	6.37e-07	1.75e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK3—breast cancer	6.27e-07	1.72e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—breast cancer	6.2e-07	1.7e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—breast cancer	6.18e-07	1.69e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—breast cancer	6.13e-07	1.68e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—breast cancer	6.1e-07	1.67e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—breast cancer	6.08e-07	1.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—breast cancer	6.08e-07	1.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—breast cancer	6.08e-07	1.67e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—breast cancer	6.06e-07	1.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—breast cancer	6.02e-07	1.65e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—breast cancer	5.97e-07	1.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—breast cancer	5.96e-07	1.63e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—breast cancer	5.93e-07	1.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—breast cancer	5.88e-07	1.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—breast cancer	5.76e-07	1.58e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—breast cancer	5.76e-07	1.58e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—breast cancer	5.73e-07	1.57e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—breast cancer	5.64e-07	1.54e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NOS3—breast cancer	5.63e-07	1.54e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—breast cancer	5.53e-07	1.52e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—breast cancer	5.38e-07	1.47e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—breast cancer	5.3e-07	1.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	5.26e-07	1.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—breast cancer	5.25e-07	1.44e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—breast cancer	5.2e-07	1.42e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	5.18e-07	1.42e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—breast cancer	5.15e-07	1.41e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—breast cancer	5.09e-07	1.39e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—breast cancer	5.01e-07	1.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—breast cancer	4.87e-07	1.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—breast cancer	4.79e-07	1.31e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—breast cancer	4.66e-07	1.28e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—breast cancer	4.58e-07	1.26e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—breast cancer	4.49e-07	1.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—breast cancer	4.39e-07	1.2e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—breast cancer	4.3e-07	1.18e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—breast cancer	4.23e-07	1.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—breast cancer	4.06e-07	1.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—breast cancer	3.74e-07	1.02e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—breast cancer	3.71e-07	1.02e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—breast cancer	3.32e-07	9.1e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—breast cancer	3.17e-07	8.68e-06	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—breast cancer	3.05e-07	8.37e-06	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—breast cancer	3.03e-07	8.3e-06	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—breast cancer	2.59e-07	7.09e-06	CbGpPWpGaD
